Compare Asian CDMOs across India, China, Japan, South Korea, and Southeast Asia. Filter by manufacturing type, regulatory approvals, and capacity for API synthesis, biologics, and drug products.
748 companies listed
Every country below has its own page with a ranked CDMO list, a country-zoomed facilities map, and the local regulatory picture. Counts are live manufacturing-site totals.
India
Kemwell Biopharma is one of India's largest biologics CDMOs, providing integrated drug substance and drug product development and manufacturing services from a single site in Bangalore. Established with technological support from a leading German biopharmaceutical company, Kemwell serves global pharma and biotech organizations with capabilities spanning monoclonal antibodies, complex fusion proteins, recombinant proteins, and bispecific antibodies. The company has received U.S. FDA approval for commercial drug product manufacturing and operates hybrid biomanufacturing with both stainless steel and single-use bioreactor systems.
China
KinOmega Biopharm Inc. is a leading Chinese manufacturer of Omega-3 fish oil EPA/DHA, producing both pharmaceutical-grade (API) and nutraceutical-grade products. They hold 9 DMFs, 4 GMP approvals (US FDA, Korean FDA, Japan PMDA), and CEP/COS certification for pharmaceutical-grade purity. Their FDA-registered facility (FEI 3009754809) has been inspected with 0 observations. KinOmega uses proprietary 3-times molecular distillation purification with 11-stage SPD technology. They also operate a softgel production line (4 million capsules/day). This is an API and ingredient manufacturer, not a contract drug product CDMO. Their products meet Ph. Eur. and USP standards.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.